These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7756675)

  • 1. Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes.
    Bertram J; Palfner K; Killian M; Brysch W; Schlingensiepen KH; Hiddemann W; Kneba M
    Anticancer Drugs; 1995 Feb; 6(1):124-34. PubMed ID: 7756675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of multidrug resistance gene (mdr-1) with antisense oligodeoxynucleotides.
    Liu C; Qureshi IA; Ding X; Shan Y; Huang Y; Xie Y; Ji M
    Clin Sci (Lond); 1996 Jul; 91(1):93-8. PubMed ID: 8774266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
    Nakashima E; Matsushita R; Negishi H; Nomura M; Harada S; Yamamoto H; Miyamoto K; Ichimura F
    J Pharm Sci; 1995 Oct; 84(10):1205-9. PubMed ID: 8801335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules.
    Dassow H; Lassner D; Remke H; Preiss R
    Int J Clin Pharmacol Ther; 2000 Apr; 38(4):209-16. PubMed ID: 10783831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of P-glycoprotein-mediated drug resistance by hsp 90 beta.
    Bertram J; Palfner K; Hiddemann W; Kneba M
    Anticancer Drugs; 1996 Nov; 7(8):838-45. PubMed ID: 8991187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of P-glycoprotein-mediated multidrug resistance in a doxorubicin-resistant subline of the human lymphoblastoid cell line CCRF-CEM by phosphorothioate antisense oligonucleotides.
    Dassow H; Lassner D; Remke H; Preiss R
    Int J Clin Pharmacol Ther; 1998 Feb; 36(2):93-6. PubMed ID: 9520155
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reversal of multidrug resistance of leukemia cell line in vitro by antisense phosphorothioate oligonucleotide].
    Chen Y; Chen Z; Zhuo G; Hu J
    Zhonghua Nei Ke Za Zhi; 1999 Jun; 38(6):373-6. PubMed ID: 11798669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines.
    Daly C; Coyle S; McBride S; O'Driscoll L; Daly N; Scanlon K; Clynes M
    Cytotechnology; 1996; 19(3):199-205. PubMed ID: 8862007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides.
    Stewart AJ; Canitrot Y; Baracchini E; Dean NM; Deeley RG; Cole SP
    Biochem Pharmacol; 1996 Feb; 51(4):461-9. PubMed ID: 8619891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells.
    Kiehntopf M; Brach MA; Licht T; Petschauer S; Karawajew L; Kirschning C; Herrmann F
    EMBO J; 1994 Oct; 13(19):4645-52. PubMed ID: 7925305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of hammerhead ribozymes cleaving mdr-1 mRNA.
    Palfner K; Kneba M; Hiddemann W; Bertram J
    Biol Chem Hoppe Seyler; 1995 May; 376(5):289-95. PubMed ID: 7544982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
    Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
    Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line.
    Rivoltini L; Colombo MP; Supino R; Ballinari D; Tsuruo T; Parmiani G
    Int J Cancer; 1990 Oct; 46(4):727-32. PubMed ID: 1976601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
    Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
    Alahari SK; Dean NM; Fisher MH; Delong R; Manoharan M; Tivel KL; Juliano RL
    Mol Pharmacol; 1996 Oct; 50(4):808-19. PubMed ID: 8863825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotide modulation of multidrug resistance.
    Bouffard DY; Ohkawa T; Kijima H; Irie A; Suzuki T; Curcio LD; Holm PS; Sassani A; Scanlon KJ
    Eur J Cancer; 1996 Jun; 32A(6):1010-8. PubMed ID: 8763342
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
    Chao CC
    FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.
    Massart C; Gibassier J; Raoul M; Pourquier P; Leclech G; Robert J; Lucas C
    Anticancer Drugs; 1995 Feb; 6(1):135-46. PubMed ID: 7756676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.